Last reviewed: May 28, 2026 Last updated: May 28, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Recent studies have also explored its potential in reducing pain and inflammation in the digestive tract, indicating its potential as a therapy for inflammatory bowel disease and irritable bowel syndrome
Here is the plain-English version
Research published in peer-reviewed journals describes BPC-157 mechanism of action, including its stability in human gastric juice and role in maintaining gastrointestinal mucosa integrity
B12 Injection: Pure methylcobalamin B12
A 2021 Nature Aging study by Lee and colleagues examined MOTS-c in the context of aging directly